Makes contraceptive implants and fertility drugs for women.
Jun 2026Revenue $6.13B/yrExpenses $5.64B/yr
No trend
Figures by year
Is Organon & profitable?
Yes. In the 12 months to Jun 2026, revenue was $6.13B and expenses $5.64B.
| Fiscal year to | Revenue | Expenses | Pre-tax profit |
|---|---|---|---|
| Dec 2025 | $6.22B | $5.79B | $425M |
| Dec 2024 | $6.40B | $5.60B | $807M |
| Dec 2023 | $6.26B | $5.59B | $673M |
| Dec 2022 | $6.17B | $5.05B | $1.12B |
| Dec 2021 | $6.30B | $4.78B | $1.53B |
| Dec 2020 | $6.53B | $3.78B | $2.75B |
| Dec 2019 | $7.78B | $4.08B | $3.70B |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.